**(a) In general** An online pharmacy shall display in a visible and clear manner on its homepage a statement that it complies with the requirements of this section with respect to the delivery or sale or offer for sale of controlled substances and shall at all times display on the homepage of its Internet site a declaration of compliance in accordance with this section.
**(b) Licensure** Each online pharmacy shall comply with the requirements of State law concerning the licensure of pharmacies in each State from which it, and in each State to which it, delivers, distributes, or dispenses or offers to deliver, distribute, or dispense controlled substances by means of the Internet, pursuant to applicable licensure requirements, as determined by each such State.
**(c) Internet pharmacy site disclosure information** Each online pharmacy shall post in a visible and clear manner on the homepage of each Internet site it operates, or on a page directly linked thereto in which the hyperlink is also visible and clear on the homepage, the following information for each pharmacy that delivers, distributes, or dispenses controlled substances pursuant to orders made on, through, or on behalf of, that website:
(1) The name and address of the pharmacy as it appears on the pharmacy’s Drug Enforcement Administration certificate of registration.
(2) The pharmacy’s telephone number and email address.
(3) The name, professional degree, and States of licensure of the pharmacist-in-charge, and a telephone number at which the pharmacist-in-charge can be contacted.
(4) A list of the States in which the pharmacy is licensed to dispense controlled substances.
(5) A certification that the pharmacy is registered under this part to deliver, distribute, or dispense by means of the Internet co
File SHA-256: caf5c80a4a7f93c8d120823b328630f07aba13a569f2df6c40c203b65ee36a97. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. This page displays the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Stable record: federal_law:legal_authorities:record_usc_3c6237ea6c151d45b2751a79 Source file: Laws/federal/codes/united-states-code/title-21/section-831-additional-requirements-relating-to-online-pharmacies-and-telemedicine--29d526b362.md Pages: Not recorded – Not recorded Passage SHA-256: 4b5b2ba160695191785840baec17f60e08be9f700abd6016f32fba0fd7fa30f7 Retained source evidence SHA-256: caf5c80a4a7f93c8d120823b328630f07aba13a569f2df6c40c203b65ee36a97
Source location: Title 21, Chapter 13, § 831; chapter-013-drug-abuse-prevention-and-control.md
Stored source content
**(a) In general** An online pharmacy shall display in a visible and clear manner on its homepage a statement that it complies with the requirements of this section with respect to the delivery or sale or offer for sale of controlled substances and shall at all times display on the homepage of its Internet site a declaration of compliance in accordance with this section.
**(b) Licensure** Each online pharmacy shall comply with the requirements of State law concerning the licensure of pharmacies in each State from which it, and in each State to which it, delivers, distributes, or dispenses or offers to deliver, distribute, or dispense controlled substances by means of the Internet, pursuant to applicable licensure requirements, as determined by each such State.
**(c) Internet pharmacy site disclosure information** Each online pharmacy shall post in a visible and clear manner on the homepage of each Internet site it operates, or on a page directly linked thereto in which the hyperlink is also visible and clear on the homepage, the following information for each pharmacy that delivers, distributes, or dispenses controlled substances pursuant to orders made on, through, or on behalf of, that website:
(1) The name and address of the pharmacy as it appears on the pharmacy’s Drug Enforcement Administration certificate of registration.
(2) The pharmacy’s telephone number and email address.
(3) The name, professional degree, and States of licensure of the pharmacist-in-charge, and a telephone number at which the pharmacist-in-charge can be contacted.
(4) A list of the States in which the pharmacy is licensed to dispense controlled substances.
(5) A certification that the pharmacy is registered under this part to deliver, distribute, or dispense by means of the Internet controlled substances.
(6) The name, address, telephone number, professional degree, and States of licensure of any practitioner who has a contractual relationship to provide medical evaluations or issue prescriptions for controlled substances, through referrals from the website or at the request of the owner or operator of the website, or any employee or agent thereof.
(7) The following statement, unless revised by the Attorney General by regulation: “This online pharmacy will only dispense a controlled substance to a person who has a valid prescription issued for a legitimate medical purpose based upon a medical relationship with a prescribing practitioner. This includes at least one prior in-person medical evaluation or medical evaluation via telemedicine in accordance with applicable requirements of section 309.”.
**(d) Notification**
(1) **In general** — Thirty days prior to offering a controlled substance for sale, delivery, distribution, or dispensing, the online pharmacy shall notify the Attorney General, in such form and manner as the Attorney General shall determine, and the State boards of pharmacy in any States in which the online pharmacy offers to sell, deliver, distribute, or dispense controlled substances.
(2) **Contents** — The notification required under paragraph (1) shall include—
(A) the information required to be posted on the online pharmacy’s Internet site under subsection (c) and shall notify the Attorney General and the applicable State boards of pharmacy, under penalty of perjury, that the information disclosed on its Internet site under subsection (c) is true and accurate;
(B) the online pharmacy’s Internet site address and a certification that the online pharmacy shall notify the Attorney General of any change in the address at least 30 days in advance; and
(C) the Drug Enforcement Administration registration numbers of any pharmacies and practitioners referred to in subsection (c), as applicable.
(3) **Existing online pharmacies** — An online pharmacy that is already operational as of the effective date of this section, shall notify the Attorney General and applicable State boards of pharmacy in accordance with this subsection not later than 30 days after such date.
**(e) Declaration of compliance** On and after the date on which it makes the notification under subsection (d), each online pharmacy shall display on the homepage of its Internet site, in such form as the Attorney General shall by regulation require, a declaration that it has made such notification to the Attorney General.
**(f) Reports** Any statement, declaration, notification, or disclosure required under this section shall be considered a report required to be kept under this part.
**(g) Notice and designations concerning Indian tribes**
(1) **In general** — For purposes of sections 802(52) and 882(c)(6)(B) of this title, the Secretary shall notify the Attorney General, at such times and in such manner as the Secretary and the Attorney General determine appropriate, of the Indian tribes or tribal organizations with which the Secretary has contracted or compacted under the Indian Self-Determination and Education Assistance Act [[25 U.S.C. 5301](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title25-section5301&num=0&edition=prelim) et seq.] for the tribes or tribal organizations to provide pharmacy services.
(2) **Designations**
(A) *In general* — The Secretary may designate a practitioner described in subparagraph (B) as an Internet Eligible Controlled Substances Provider. Such designations shall be made only in cases where the Secretary has found that there is a legitimate need for the practitioner to be so designated because the population served by the practitioner is in a sufficiently remote location that access to medical services is limited.
(B) *Practitioners* — A practitioner described in this subparagraph is a practitioner who is an employee or contractor of the Indian Health Service, or is working for an Indian tribe or tribal organization under its contract or compact under the Indian Self-Determination and Education Assistance Act [[25 U.S.C. 5301](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title25-section5301&num=0&edition=prelim) et seq.] with the Indian Health Service.
**(h) Special registration for telemedicine**
(1) **In general** — The Attorney General may issue to a practitioner a special registration to engage in the practice of telemedicine for purposes of [section 802(54)(E) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section802/54/E&num=0&edition=prelim) if the practitioner, upon application for such special registration—
(A) demonstrates a legitimate need for the special registration; and
(B) is registered under [section 823(g) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section823/g&num=0&edition=prelim) in the State in which the patient will be located when receiving the telemedicine treatment, unless the practitioner—
(i) is exempted from such registration in all States under [section 822(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section822/d&num=0&edition=prelim); or
(ii) is an employee or contractor of the Department of Veterans Affairs who is acting in the scope of such employment or contract and is registered under [section 823(g) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section823/g&num=0&edition=prelim) in any State or is utilizing the registration of a hospital or clinic operated by the Department of Veterans Affairs registered under [section 823(g) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section823/g&num=0&edition=prelim).
(2) **Regulations** — Not later than 1 year after October 24, 2018, in consultation with the Secretary, the Attorney General shall promulgate final regulations specifying—
(A) the limited circumstances in which a special registration under this subsection may be issued; and
(B) the procedure for obtaining a special registration under this subsection.
(3) **Denials** — Proceedings to deny an application for registration under this subsection shall be conducted in accordance with [section 824(c) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section824/c&num=0&edition=prelim).
**(i) Reporting of telemedicine by VHA during medical emergency situations**
(1) **In general** — Any practitioner issuing a prescription for a controlled substance under the authorization to conduct telemedicine during a medical emergency situation described in [section 802(54)(F) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section802/54/F&num=0&edition=prelim) shall report to the Secretary of Veterans Affairs the authorization of that emergency prescription, in accordance with such requirements as the Secretary of Veterans Affairs shall, by regulation, establish.
(2) **To Attorney General** — Not later than 30 days after the date that a prescription described in subparagraph (A) is issued, the Secretary of Veterans Affairs shall report to the Attorney General the authorization of that emergency prescription.
**(j) Clarification concerning prescription transfers** Any transfer between pharmacies of information relating to a prescription for a controlled substance shall meet the applicable requirements under regulations promulgated by the Attorney General under this chapter.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
§ 831. Additional requirements relating to online
pharmacies and telemedicine
(a) In general
An online pharmacy shall display in a visible
and clear manner on its homepage a statement
that it complies with the requirements of this
section with respect to the delivery or sale or
offer for sale of controlled substances and shall
at all times display on the homepage of its
Internet site a declaration of compliance in ac-
cordance with this section.
(b) Licensure
Each online pharmacy shall comply with the
requirements of State law concerning the licen-
sure of pharmacies in each State from which it,
and in each State to which it, delivers, distrib-
utes, or dispenses or offers to deliver, distribute,
or dispense controlled substances by means of
the Internet, pursuant to applicable licensure
requirements, as determined by each such State.
(c) Internet pharmacy site disclosure informa-
tion
Each online pharmacy shall post in a visible
and clear manner on the homepage of each
Internet site it operates, or on a page directly
linked thereto in which the hyperlink is also
visible and clear on the homepage, the following
information for each pharmacy that delivers,
distributes, or dispenses controlled substances
pursuant to orders made on, through, or on be-
half of, that website:
(1) The name and address of the pharmacy as
it appears on the pharmacy’s Drug Enforce-
ment Administration certificate of registra-
tion.
(2) The pharmacy’s telephone number and
email address.
(3) The name, professional degree, and
States of licensure of the pharmacist-in-
charge, and a telephone number at which the
pharmacist-in-charge can be contacted.
(4) A list of the States in which the phar-
macy is licensed to dispense controlled sub-
stances.
(5) A certificatio
**(a) Mandatory application** All provisions of sections 5305(b), 5306, 5307, 5321(c) and (d), 5323, 5324(k) and (l), 5325(a) through (k), and 5332 of this title and section 314 of Public Law 101–512 (coverage under chapter 171 of title 28, commonly known as the “Federal Tort Claims Act”), to the extent not in conflict with this subchapter, shall apply to compacts and funding agreements authorized by this subchapter.
**(b) Discretionary application** At the request of a participating Indian tribe, any other provision of subchapter I of this chapter, to the extent such provision is not in conflict with this subchapter, shall be made a part of a funding agreement or compact entered into under this subchapter. The Secretary is obligated to include such provision at the option of the participating Indian tribe or tribes. If such provision is incorporated it shall have the same force and effect as if it were set out in full in this subchapter. In the event an Indian tribe requests such incorporation at the negotiation stage of a compact or funding agreement, such incorporation shall be deemed effective immediately and shall control the negotiation and resulting compact and funding agreement.
Stored review status: release_metadata_unconfirmed. The source passage cites 25 U.S.C. § 5301. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
§ 5301. Congressional statement of findings
(a) Findings respecting historical and special
legal relationship, and resultant responsibil-
ities
The Congress, after careful review of the Fed-
eral Government’s historical and special legal
relationship with, and resulting responsibilities
to, American Indian people, finds that—
(1) the prolonged Federal domination of In-
dian service programs has served to retard
rather than enhance the progress of Indian
people and their communities by depriving In-
dians of the full opportunity to develop leader-
ship skills crucial to the realization of self-
government, and has denied to the Indian peo-
ple an effective voice in the planning and im-
plementation of programs for the benefit of In-
dians which are responsive to the true needs of
Indian communities; and
(2) the Indian people will never surrender
their desire to control their relationships both
among themselves and with non-Indian gov-
ernments, organizations, and persons.
(b) Further findings
The Congress further finds that—
(1) true self-determination in any society of
people is dependent upon an educational proc-
ess which will insure the development of quali-
fied people to fulfill meaningful leadership
roles;
(2) the Federal responsibility for and assist-
ance to education of Indian children has not
Page 710
TITLE 25—INDIANS
§ 5301
effected the desired level of educational
achievement or created the diverse opportuni-
ties and personal satisfaction which education
can and should provide; and
(3) parental and community control of the
educational process is of crucial importance to
the Indian people.
(Pub. L. 93–638, § 2, Jan. 4, 1975, 88 Stat. 2203.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 450 of this
title p
Stored review status: historical_2024_not_currentness_verified. The source passage cites 25 U.S.C. § 5301. This identifies an authority to review, not proof of applicability.